While adaptive biotechnologies shareholders are down 28% for the year, the market itself is up 33%. Adpt) is owned by 82.67% institutional shareholders, 59.01% adaptive biotechnologies corp insiders, and 0.00% retail investors. …
Despite the fact that adaptive biotechnologies corporation (nasdaq:adpt) stock rose 3.9% last week, insiders who sold us$229k worth of stock in the previous 12 months are likely to be better off. Adaptive biotechnologies has bee…
